Breast cancer is one of the biggest reasons of human death most especially for women and is ranked 5th as the most common cause of cancer deaths. It is one of the most common cancers worldwide, next to lung cancer. Even if it seldom happens to men, they too are also prone to having breast cancer, just like women.

 With continuously increasing awareness, fatalities are fortunately lessening each year. With the tremendous efforts made by some respected individuals and groups they help spread breast cancer awareness throughout the world. More and more people are becoming informed about how to get it diagnosed, how to prevent it and how essential it is to have a regular check up.

 There is no truth that wearing a bra while sleeping or wearing a brassiere with under-wire can cause breast cancer. Although certain instructions are broadcast worldwide on how to self-check whether a woman has lumps on or near the breast that can cause cancer, this is usually discovered at a rather advanced stage. But self-breast examination is still very much advised, althought it is much better to have an actual screening, to find it out at an early stage and have breast cancer treatments if needed.

 The breast cancer screening may include several types of exams such as x ray mammogram, a physical breast exam conducted by your attending physician, a breast MRI and others. Although these exams will not cure the cancer, these are very effective ways to discover if there is any presence of lumps and other symptoms that can lead to breast cancer. If ever lumps are found, additional examinations are done in order to identify if the lump is malign or not and take action to keep it from getting worse.

 Genetics is also a big element in detecting if a person has greater chances of having breast cancer. The earlier the detection of a lump, the better chance of survival is assured. Although it doesn’t mean that cancer in the advanced stage cannot be cured anymore. What we are just trying to say is that every woman should take extra care of their health. Every pain they feel no matter whichever part of their body shouldn’t just be taken for granted. The truth is, even if there’s no pain at all regular checkups are still recommended. Not just to detect if you have a breast cancer or not but to be prepared as well, as with any other kind of diseases a person may have. In the end, just remember that some kinds of illnesses, such as breast cancer for example, can be a traitor that will just take away your life if not given proper attention and medication.

 Discover how a breast cancer screening can help save your life. Visit the site to learn more about breast cancer.

Presence of the ER is necessary but not sufficient for estrogen dependence. Clinically, therapy of endocrine appears to reduce recurrence in the adjuvant setting by only about 40%. Only about 40% of patients with ER-rich metastatic disease will benefit from endocrine therapy, and almost all patients with metastatic disease will ultimately become resistant to all forms of endocrine therapy, even though their tumors may still express ER. Therefore, additional predictive factors of breast cancer pink are needed to help in the selection of patients who are very unlikely to respond to endocrine therapy, so that alternative treatments such as more toxic chemotherapy can be recommended. However, such factors must, like ER, separate these two groups with almost absolute precision, since most patients with breast cancer are willing to accept the relatively low toxicity of endocrine therapy for a very small chance of benefit. Thus far, no such factor has been identified. Several relatively weak predictive factors seem to separate ER-positive patients into those who are more or less like to respond, but not with the accuracy that would lead one to withhold endocrine treatment. Of these, the members of the HER family, especially HER-2, appear particularly interesting. Several preclinical and clinical studies and cancer facts (although not universally) have suggested that ER-positive HER-2–positive tumors are less responsive to endocrine agents, suggesting “cross-talk” between the HER peptide growth factor and ER steroid growth factor axes.

The Cancer Partnership is the result of a first-ever collaboration between four leading medical groups – Providence Everett Medical Center, The Everett Clinic, Western Washington Medical Group and Northwest Washington Radiation Oncology Associates. The Cancer Partnership hosts some of the most sought-after cancer technology never before available in the Puget Sound region. It offers all aspects of outpatient cancer care under one roof. In this interview, Dr. Soriano addresses breast cancer treatment, The Everett Clinic, and the Cancer Partnership.

Interview with Dr. Perry Soriano MD, The Everett Clinic

DR. SORIANO: We have a Cancer Conference, at the Cancer Partnership, where we have our pathologists, our radiation oncologists, medical oncologists. Then we have our surgeons present and we have the research coordinator present, to talk about recent trials that may be pertinent to that patient.

And then the group comes to a consensus and we’ll issue a recommendation. The recommendation is brought back to the patient. Then we decide, between the patient and the direct caregivers, what’s the best course.

INTERVIEWER: Do all of your cancer patients have this team that is looking at their particular case, or is that a regular procedure? In other words, if I had my cancer treated here, at The Everett Clinic, would this really expert team be looking at my case and making recommendations?

DR. SORIANO: Yes, the majority of our cancer cases do come before the multidisciplinary tumor board. So, all of our breast cancer diagnoses, that are diagnosed within our system, are actually brought to the breast cancer and multidisciplinary tumor board. And the majority of our complex gastrointestinal cancers are also reviewed at the gastrointestinal tumor board.

The majority of our cases do undergo review. There are some cases where the multidisciplinary cure is accomplished by meeting individually with the specialists, and may not come for review. If the case is fairly straightforward… Of course no one’s case is really straightforward, everyone is an individual. So, all breast cancers are reviewed, and the majority of GI cases are reviewed as well.

The Everett Clinic is Snohomish County’s premier health care provider, with over 275 physicians. Specialty-trained physicians at the Everett Clinic practice in over 40 areas of expertise. Many are fellowship trained in advanced disciplines such as laparoscopic surgery, urological oncology, total joint replacement and more.

The Everett Clinic has many locations throughout Snohomish County, including Starwood, Marysville, Lake Stevens, Mill Creek and, of course, Everett. The Everett Clinic has four pharmacies, an advanced imagining center (offering MRI, CT, ultrasound and more), two outpatient surgery centers, vision and hearing aid centers and much more.

We do not know what causes breast cancer, although we do know that certain risk factors may put you at higher risk of developing it. A person’s age, factors of genetic, personal health history and diet all contribute to breast cancer risk.

Breast cancer is when the cells in a woman’s body begin to grow and reproduce out of control, which creates a collection of tissue called a tumor. However, just because you have a tumor in the breast does not mean it has to be cancerous.
In case the cells that are growing out of control are normal cells, the tumor isn’t cancerous. However, if the cells that are growing out of control are abnormal and does not function like the body’s normal cells, the tumor is cancerous.
Cancers are named after the part of the body from which they originate. Cancer of breast originates in the breast tissue. Like other cancers, breast cancer can infect and grow into the tissue surrounding the breast. It can also pass through to other parts of the body and form new tumors. This course of action is also called metastasis.

Breast cancer is the most common cancer among American women, after nonmelanoma skin cancer. Over the past 50 years, the number of women diagnosed with the disease has increased each year.
Today, approximately one in almost every eight women (13.4%) will develop cancer of breast in her lifetime. Breast cancer is the second-leading cause of cancer death in women after lung cancer. It is the leading cause of cancer death among women ages 35 to 54.

The American Cancer Society estimates that in 2005, approximately 211,240 women will be diagnosed with invasive breast cancer and approximately 40,410 will die. Although these numbers may sound frightening, research tells us that the death rate could decrease by 30% if all women age 50 and older who need a mammogram had one.

Only 5-11% of breast cancers occur in women with a clearly defined genetic predisposition for the disease. The majority of breast cancer is not related to their history of family. The risk for developing breast cancer increases as a woman ages.

Breast self-examination should be performed at the same time each month, three to five days after your menstrual period ends. If you have stopped menstruating, perform the exam on the same day of the month. To perform a breast self-exam, follow the steps described below.

In the mirror:

1. Stand undressed from the waist up in front of a large mirror in a well-lit room. Look at your breasts. Do not be alarmed if they do not look equal in size or shape. Most women’s breasts are not. With your arms relaxed by your sides, look for any changes in size, shape or position, or any changes to the skin of the breasts. Look for any skin puckering, dimpling, sores or discoloration. Inspect your nipples and look for any sores, peeling or change in the direction of the nipples.

2. After that, place your hands on your hips and press down firmly to tighten the chest muscles beneath your breasts. Turn from side to side in order to inspect the outer part of your breasts.

3. Then bend forward toward the mirror. Roll your shoulders and elbows forward to tighten your chest muscles. Your breasts will fall forward. Look for any changes in the shape or contour of your breasts.

4. Now, clasp your hands behind your head and press your hands forward. Again, turn from side to side to inspect your breasts’ outer portions. Remember to inspect the border underneath your breasts. You may need to lift your breasts with your hand to see this area.

5. Check your nipples for discharge (fluid). Place your thumb and forefinger on the tissue surrounding the nipple and pull outward toward the end of the nipple. Look for any discharge. Repeat on your other breast.
In the shower
6. Now, it is time to feel for changes in the breast. It’s helpful to have your hands slippery with soap and water. Check for any lumps or thickening in your underarm area. Place your left hand on your hip and reach with your right hand to feel in the left armpit. Repeat on the other side.

7. Check both sides for lumps or thickenings above and below your collarbone.

8. With hands soapy, raise one arm behind your head to spread out the breast tissue. Use the flat part of your fingers from the other hand to press gently into the breast. Follow an up-and-down pattern along the breast, moving from bra line to collarbone. Continue the pattern until you have covered the entire breast. Repeat on the other side.

By: Zallhack Froontier

Most sorts of breast cancer are simple to identify by microscopic investigation with the biopsy. There are however, scarcer kinds of breast cancer which call for specialized lab tests and only an experienced professional might possess the coaching to identify those and pass a medical diagnosis. For that reason, it’s important exactly who you entrust along with your medical tests and exams. Speak to the doctor and find out what steps must be taken for correct diagnosis.

The precise diagnosis results in specific remedy for the precise variety of breast cancer in question. The physician wants to tailor remedy to thus fit individual prognosis as well as the individual’s personality. The several treatment alternatives should be mentioned with each other to be able to come up with all the very best course of motion. All the benefits and drawbacks ought to become reviewed and presented towards the client, in order that the woman is aware of what things to expect and to be aware of what it’s normal towards the stage of remedy that she’s proceeding through.

Troubles in treatment might come up while breast cancer includes more than just one location of malignancy. It’s critical that the physician looks into past the immediate site of the growth, due to the fact secondary locations may well appear within the mammograms after which, distinct treatments will be required. If such is your case, the expert would most definitely advise other exams like ultrasound examination, MRI and numerous imaging strategies to help make sure that the rest of the body has not been affected through the cancer malignancy.

Complicated strategies to support girls affected by breast cancer are carried out almost all through the globe. Their aim is to help wholesome women at the same time to stop and shield their well being by regular breast assessments that may well permit for the identification inside the early stages of a mammal tumor. In under-developed countries, breast cancer is really a quantity one major cause in females. This is surely a scenario to fight against, and never admit without doing something. We owe it to our wives, moms and daughters!

LCIS remedies selections are a little distinct. They include observation to ascertain adjustments, hormone treatment to avoid cancer from developing, or bilateral prophylactic (preventive) mastectomies.

Things get additional complicated when your cancer spreads beyond the ducts or lobes/lobules. After your cancer has been staged, you could pay a visit to http://www.cancer.gov to establish your therapy alternatives. They will normally include things like: surgery, chemotherapy, radiation, and/or hormone therapy. For IBC, remedy options are similar for the other types of breast cancer, however they will always consist of chemotherapy for the reason that of its aggressiveness.

o Surgery: Breast surgery might be either a lumpectomy, where the tumor is removed, or perhaps a partial or modified radical mastectomy. Using a lumpectomy, it truly is commonly followed by radiation. This way, you get to help keep your breast and studies have shown no difference in survival rates in between lumpectomy/radiation and mastectomy.

Note: Not too extended ago, they utilised to carry out radical mastectomies exactly where the breast, all the lymph nodes, plus the underlying muscle were cut away. Thankfully, medicine has found that’s not crucial. Now, a partial or modified radical mastectomy is performed, exactly where either component with the breast tissue, or the whole breast, and possibly a portion of the lymph nodes, are removed. On the complete, a mastectomy is not too bad a surgery, though everyone is distinct. I found both of mine to become fairly easy, but you’ll wake up with drain tubes, which you are going to normally have for no less than a week.

o Chemotherapy: Chemotherapy is defined by Wikipedia as “the use of chemical substances to treat condition. In its modern-day use, it refers mostly to cytotoxic drugs applied to treat cancer.” This can be a frightening prospect for any individual. We’ve all heard horror stories about how extremely debilitating chemotherapy is often. Nonetheless, considerably progress has been made in the management of chemo’s negative effects, towards the point that, once you have the correct management tools, you’ll be able to continue to like the activities you usually do. Chemo is actually a usually means of treating your cancer systemically and is ordinarily advised for those whose tumor is larger than a selected size and/or the cancer has spread to your lymph nodes. The thinking is that if your cancer has had the possibility to access the rest of your body, your treatment must be systemic too.

o Radiation: Radiation treatment is ordinarily a localized therapy solution, where rapidly dividing cells are damaged. Cancer cells are extremely rapid dividers, so radiation is an helpful selection. Ordinarily, radiation therapy is given for about six weeks, five days a week. It is quite a lot like lying nonetheless for an x-ray, only instead of lasting a second or two, it lasts a few minutes. It may bring about fatigue, toward the end and slightly following, and can result in a sunburn impact on your skin.

o Hormone Treatment: Quite a few breast cancers are hormone-dependent. In these cancers, there are actually receptors on the tumor which will be filled with estrogen. The thinking is that when estrogen fills these receptors, it causes the tumor to develop. This really is referred to as estrogen-receptor constructive (ER). These cancers respond properly to hormone therapy and also the hormone treatment drug that may be suggested for you will depend on your menopausal status. These drugs are in pill form and also you take them once each day. By far the most favorite of those drugs, for pre-menopausal ladies, is Tamoxifen and, for post-menopausal women Femara or Arimidex. There is certainly new evidence that suggests that taking Femara, after taking Tamoxifen for five years, increases survival rates.

o Immunotherapy: There’s a fourth modality of treatment on the horizon and it is called Immunotherapy. This entails acquiring your immune system to fight your cancer and there is, and will be, plenty of homework becoming done in this region.

Associated articles you might be thinking about:

- Breast Cancer Radiation Side Effects

- Raising Money For Breast Cancer

- First Sign Of Breast Cancer

Additive endocrine therapies, in principle, function by direct action on the hormonally dependent breast cancer recurrence cell. In that regard, estrogen production persists, but its action is blocked at the cellular stages by interfering with estrogen and its receptor. Enigmatically, the first such agents to be used successfully were estrogenic compounds (diethylstilbestrol, ethyinylestradiol) administered at pharmacological doses, although androgenic agents were also found to be marginally effective. Subsequently, estrogenic agents were replaced by the equally active but less toxic triphenylethylamine tamoxifen, which was originally considered to be an “antiestrogen.” Subsequent studies have demonstrated that tamoxifen has dualistic agonist and antagonist activity, depending on the tissue of interest.

Consequently, tamoxifen and other cancer rates agents like it have been designated selective estrogen-receptor modifiers (SERMs).

Other hormonal therapies—such as progestational agents (megestrol, medroxyprogesterone acetate) and androgens—have been harder to classify. Both of these types of treatments have been proven to be active against breast cancer, although they have been largely replaced or relegated to third or fourthline therapy by newer, more active and tolerable agents. In theory, they could exert their effects at the cellular level and would thus be classified with the SERMs as additive agents. On the other hand, neither progesterone nor androgen receptors appear to be fundamentally important for breast cancer behavior, nor neither antiprogestin nor antiandrogen therapy has been particularly successful against breast cancer. For That reason, it has been speculated that the mechanism of action of progestins and androgens may be a consequence of suppression of the hypothalamic- pituitary axis via a feedback mechanism. In this case, one may consider these strategies as ablative.

Find the related articles about cancer: symptoms of colon cancer

Although Beatson concluded that this effect was secondary to a neurological link between the organs, we now know that he was removing a molecular growth factor (estrogen) from a dependent blood cancer. By midcentury, endocrine therapy, consisting of oophorectomy for young women and pharmacological doses of estrogenic compounds for post-menopausal women, was the therapy of choice in advanced disease. Some of the earliest prospective randomized clinical trials in all of medicine addressed adjuvant oophorectomy. These trials demonstrated reductions in distant recurrence and mortality and remain positive to this day. Since then, several surgical and medical approaches have been introduced that have improved the efficacy and safety of endocrine therapy and breast cancer chemo directed toward the ER pathway.

Coupled with the high incidence of breast cancer in the western world affecting a relatively young population, the substantial life prolonging benefits of ER-based endocrine therapy may result in more life-years saved than any other active anticancer therapy. Therefore, a thorough understanding of endocrine therapy is essential for any student or practitioner involved with breast cancer and should serve as a primer for the emerging peptide-hormone based therapies during the next decade.

Fundamentally, endocrine therapy has been divided into two categories: ablative and additive. Ablative treatments are directed toward removing the sources of estrogen, which are primarily the ovaries in premenopausal women and the adrenal glands in postmenopausal women. Initial ablative therapies were accomplished by surgical or radiation-induced ablation of hormone-producing organs, but more recently the goal of estrogen deprivation can be accomplished by chemical indicates. Surgical ablative therapies can be direct, such as oophorectomy or adrenalectomy, or indirect, such as hypophysectomy. In premenopausal women, “chemical castration” can be obtained by the administration of agonists and/or antagonists of luteinizing hormone–releasing hormone (LHRH), which prevent production of luteinizing hormone and therefore block ovarian estrogen production. In postmenopausal women, most if not all estrogen production stems from conversion of adrenal steroid precursors to estradiol by aromatase activity, either in peripheral adipose tissue or even within the breast cancer symptoms itself.

Other peptide growth factor pathways are also under investigation as either de novo axes that breast cancer cells might exploit for hormone independence or as upregulated systems that result in emergence of resistance to endocrine therapy.

These include the insulin-like growth factors (IGF-1 and IGF-2) and associated receptors and other, less well studied axes, such as that signaled through NOTCH receptors (a highly conserved receptor family involved in the regulation of cell differentiation, proliferation, and apoptosis in many cell types). Although none of the studies of non-HER pathways has attained clinical utility, it seems likely that future investigations will be fruitful.

These considerations raise a second question: “How can resistance to ER directed therapy be overcome?” A critical subcomponent of this question is whether all breast cancers derive from stem cells that are initially estrogendependent or whether two (or more) stem cell components exist: one estrogen dependent and the other not. If the latter is the case, then one might expect that more effective therapies directed toward the ER would substantially reduce or eliminate the burden of breast cancer. Such strategies might include development of new agents that block the estrogen-ER pathway more effectively, either by additive or ablative means. These might include drugs that work via similar mechanisms to existing agents, like the SERMs, the aromatase inhibitors, or the gonadatropin releasing factor agonists/antagonists. Alternatively, it’s conceivable that pharmacological modulation of the ER corepressors and coinhibitors, or of the steroid or peptide growth factor pathways that interact with ER, might be effective strategies. Future preclinical and clinical research are likely to move in these directions.

The Cancer Partnership is the result of a first-ever collaboration between four leading medical groups – Providence Everett Medical Center, The Everett Clinic, Western Washington Medical Group and Northwest Washington Radiation Oncology Associates. The Cancer Partnership hosts some of the most sought-after cancer technology never before available in the Puget Sound region. It offers all aspects of outpatient cancer care under one roof. In this interview, Dr. Neuger addresses breast cancer treatment, The Everett Clinic, and communication between departments.

Interview with Dr. Elizabeth L. Neuger, MD, The Everett Clinic

INTERVIEWER: How do you coordinate care after the surgery with primary care physicians, and how are you intertwined with that?

DR. NEUGER: Everett Clinic patients are so easy to care for because of the computer program. When I see a patient post-operatively and I clear them from a surgical point of view, my note gets sent immediately to the primary care doctors, and they have it at their fingertips. The oncologists have it at their fingertips, especially for breast cancer.

Our breast cancer program in The Everett Clinic is as good as any breast cancer program around. You know, having been at the University of Washington and here… There’s nothing better than what we have here.

Communication is absolutely one of the most important things in patient care. Whether it between the radiologist, the oncologist, the primary care doc. And, even though the breast center itself isn’t part of The Everett Clinic, we actually meet weekly with the radiologist, with the pathologist, with the radiation oncologist, the cancer doctors, the physical therapist, the people running the clinical trials… We all meet as a group weekly to discuss these patients. Breast patients are discussed that way. Primary care patients, we discuss with them. Patients who don’t have cancer… It’s just easy communication.

INTERVIEWER: Is that a unique model to care here? I’ve never heard of such a diverse group of experts coming together and discussing individual cases, one at a time.

DR. NEUGER: I think for breast cancer you’ll find that in various places, in various degrees. I can say that the breast cancer conference we hold here is very well-attended by all specialties. I can’t think of a time where we didn’t have all breast cancer specialties covered at the conference.

I can’t speak as to whether or not that’s true everywhere. I know that every patient who comes through our breast center, who has the diagnosis of breast cancer, gets filtered into that conference. You know a lot of places, the doctors have to call and request that the patients be put into the conference. Every patient who gets diagnosed at the breast center here shows up on the conference list.

The patients don’t go to this conference. This is where the doctors sit around and we look at every x-ray, we look at the pathology slides. You know, most surgeons just look at the pathology report. We actually look at the pathology slides, where we say “This is the cell, this is the margin, is this an adequate margin?” I sit next to my friend, who’s a radiation oncologist, who also is a specialist in their field? And they say, “Yes, that’s an adequate margin,” or, “No, you need to go back and do more.”

You know, just last month a paper came out about how to treat auxiliary node disease in breast cancer which is changing. It used to be that if you had a positive sentinel node, you would take all the lymph nodes out. Well, this paper came out last month, and we were already talking about it at our conference this morning… We had a patient who fit the criteria, who had a positive sentinel node, who now will be spared another surgical procedure because of this new paper that came out just a month ago.

The Everett Clinic is Snohomish County’s premier health care provider, with over 275 physicians. Specialty-trained physicians at the Everett Clinic practice in over 40 areas of expertise. Many are fellowship trained in advanced disciplines such as laparoscopic surgery, urological oncology, total joint replacement and more.

The Everett Clinic has many locations throughout Snohomish County, including Starwood, Marysville, Lake Stevens, Mill Creek and, of course, Everett. The Everett Clinic has four pharmacies, an advanced imagining center (offering MRI, CT, ultrasound and more), two outpatient surgery centers, vision and hearing aid centers and much more.